Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies

NCT00266279 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Head or Neck Cancer

Interventions

DRUG: Oxaliplatin, Capecitabine

Sponsor

University of Louisville

Collaborators

[object Object]